Cutting-Edge Diagnostic Solutions Accelerate Diagnostics offers state-of-the-art in vitro diagnostic solutions that significantly reduce the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit automate sample preparation to deliver phenotypic antibiotic susceptibility results in approximately 7 hours, giving clinicians the ability to optimize treatment faster than traditional methods.
Competitive Edge in Antibiotic Resistance Amid global challenges of antibiotic resistance, Accelerate Diagnostics stands out with solutions that provide results 1-2 days faster than existing methods. This competitive advantage enhances patient care with quicker, tailored antibiotic selection, making it an attractive option for healthcare facilities aiming to improve treatment outcomes and combat antibiotic resistance effectively.
Revenue and Growth Potential With a revenue ranging between $50M - 100M and recent funding of $15M, Accelerate Diagnostics demonstrates financial stability and growth potential. This indicates a company that is well-positioned to invest in further innovation, expansion, and market penetration, presenting a lucrative sales opportunity for partners looking to collaborate with a financially healthy organization.
Addressing Critical Healthcare Needs Acceleration Diagnostics is dedicated to addressing critical healthcare needs related to sepsis and antibiotic resistance. Its advanced diagnostic tools and technologies directly contribute to improving patient outcomes by providing timely and accurate information for clinicians to make informed decisions. Partnering with Accelerate Diagnostics presents an opportunity to support healthcare providers in meeting these pressing challenges effectively.
Expanding Market Reach Located in Tucson, Arizona, Accelerate Diagnostics has positioned itself to tap into the growing medical equipment manufacturing market. With its focus on combating antibiotic resistance and sepsis, the company can leverage its innovative solutions to expand its market reach and partner with healthcare institutions globally, making it an appealing prospect for sales expansion into new territories.